In conclusion, to the best of our knowledge, this is the first study to show an EZH2 SNP having a significant impact on CCA outcome, possibly through its role in the PPAR-α/RXR-α complex interaction with EZH2. This evidence concerns the gene EZH2 and cholangiocarcinoma.